PHILADELPHIA Aug. 9 2017 PRNewswire Aevi Genomic Medicine Inc. NASDAQ GNMX the Company announced today financial and operational results for the quarter ended June 30 2017 and provided a corporate update. Second Quarter Corporate Highlights Ini...
↧